Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation-Reference-Cited by-同舟云学术

Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation

Author:

O'Leary Jacqueline G.¹,Kaneku Hugo²,Jennings Linda W.¹,Bañuelos Nubia³,Susskind Brian M.¹,Terasaki Paul I.²³,Klintmalm Göran B.¹

Affiliation:

1. Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center; Dallas TX

2. University of California Los Angeles; Los Angeles CA

3. Terasaki Foundation Laboratory; Los Angeles CA

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

Reference38 articles.

1. The antibody crossmatch in liver transplantation;Gordon;Surgery,1986

2. Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy;Takaya;Transplant Proc,1991

3. Significance of a positive crossmatch on outcome in human liver transplantation;Ogura;Transplant Proc,1992

4. Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation;Mañez;Transplant Proc,1993

5. The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis;Nakamura;Transplant Proc,1991

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献